DGIdb - TOLBUTAMIDE Drug Record

TOLBUTAMIDE chembl:CHEMBL782 Approved

Alternate Names:

NSC-87833
RASTINON
GLYCONON
PRAMIDEX
TOLBUTAMIDE
ORINASE
NSC-23813
N-(SULFONYL-P-METHYLBENZENE)-N'-N-BUTYLUREA
1-BUTYL-3-(P-METHYLPHENYLSULFONYL)UREA
1-BUTYL-3-(P-TOLYLSULFONYL)UREA
3-(P-TOLYL-4-SULFONYL)-1-BUTYLUREA
N-(P-METHYLBENZENESULFONYL)-N'-BUTYLUREA
N-N-BUTYL-N'-TOSYLUREA
1-P-TOLUENESULFONYL-3-BUTYLUREA
N-BUTYL-N'-P-TOLUENESULFONYLUREA
1-BUTYL-3-TOSYLUREA
N-(4-METHYLBENZENESULFONYL)-N'-BUTYLUREA
N-BUTYL-N'-(4-METHYLPHENYLSULFONYL)UREA
ORINASE (TN)
N-BUTYL-N'-(P-TOLYLSULFONYL)UREA
TOLBUTAMIDUM
TOLYLSULFONYLBUTYLUREA
TOLBUTAMIDA
N-(4-METHYLPHENYLSULFONYL)-N'-BUTYLUREA
TOLBUTAMIDE SODIUM
ORINASE®
chembl:CHEMBL782
drugbank:01124
pubchem.compound:5505
chemidplus:64-77-7
rxcui:10635

Drug Info:

Year of Approval	approved before 1982
Drug Class	hypoglycemic agents
FDA Approval	Approved before 1982
Drug Class	small molecule
Drug Indications	Hypoglycemic Agents

(3 More Sources)

Publications:

Mizuno et al., 2008, Type 2 diabetes and oral antihyperglycemic drugs., Curr. Med. Chem.
Smith et al., 1998, Inhibition of the ATP-sensitive potassium channel from mouse pancreatic beta-cells by surfactants., Br. J. Pharmacol.
Liu et al., 1999, ATP-dependent activation of K(Ca) and ROMK-type K(ATP) channels in human submandibular gland ductal cells., J. Biol. Chem.
Proks et al., 2001, Interaction of stilbene disulphonates with cloned K(ATP) channels., Br. J. Pharmacol.
Jones BC et al., 1996, Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase)., Drug Metab Dispos
Chen H et al., 2020, An identification and functional evaluation of a novel CYP2C9 variant CYP2C9*62., Chem Biol Interact
Gao N et al., 2016, Gene polymorphisms and contents of cytochrome P450s have only limited effects on metabolic activities in human liver microsomes., Eur J Pharm Sci
Dai DP et al., 2015, Identification and Functional Assessment of a New CYP2C9 Allelic Variant CYP2C9*59., Drug Metab Dispos
Blaisdell J et al., 2004, Discovery of new potentially defective alleles of human CYP2C9., Pharmacogenetics
Kirchheiner J et al., 2002, Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers., Pharmacogenetics
Ibeanu GC et al., 1999, A novel transversion in the intron 5 donor splice junction of CYP2C19 and a sequence polymorphism in exon 3 contribute to the poor metabolizer phenotype for the anticonvulsant drug S-mephenytoin., J Pharmacol Exp Ther
Ibeanu GC et al., 1998, An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians., Pharmacogenetics

TOLBUTAMIDE KCNJ1

Interaction Score: 3.4

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
9647478 10455193 11226127

Sources:
TdgClinicalTrial TEND
TOLBUTAMIDE ABCC8

Interaction Score: 1.56

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
18220763

Sources:
ChemblInteractions TTD
TOLBUTAMIDE ABCC9

Interaction Score: 0.98

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
TOLBUTAMIDE KCNJ11

Interaction Score: 0.32

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
TOLBUTAMIDE G6PD

Interaction Score: 0.25

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB FDA
TOLBUTAMIDE CYP2C9

Interaction Score: 0.15

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
8742240 32531309 27339126 25994031 15284535 11875364

Sources:
PharmGKB
TOLBUTAMIDE CYP2C19

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
10411572 10022751

Sources:
PharmGKB

TEND: TOLBUTAMIDE
- Version: 01-August-2011
Alternate Names:

TOLBUTAMIDE Primary Drug Name

Drug Info:

Drug Class hypoglycemic agents

Year of Approval approved before 1982

Publications:
TdgClinicalTrial: TOLBUTAMIDE
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications Hypoglycemic Agents

Drug Class small molecule

FDA Approval Approved before 1982

Publications:

PharmGKB: tolbutamide

Version: 18-August-2020

Alternate Names:

Drug Info:

Publications:

Blaisdell J et al., 2004, Discovery of new potentially defective alleles of human CYP2C9., Pharmacogenetics

Jones BC et al., 1996, Putative active site template model for cytochrome P4502C9 (tolbutamide hydroxylase)., Drug Metab Dispos

Kirchheiner J et al., 2002, Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers., Pharmacogenetics

TTD: Tolbutamide
- Version: 2020.06.01
Alternate Names:

D06OIV TTD Drug ID

Drug Info:

Publications:
ChemblInteractions: CHEMBL782
- Version: chembl_23
Alternate Names:

Drug Info:

Publications:
ChemblDrugs: chembl:CHEMBL782
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:
FDA: Tolbutamide
- Version: 04-September-2020
Alternate Names:

Drug Info:

Publications:

Mechanism of Interaction	Sulfonylurea receptor 1, Kir6.2 blocker
Direct Interaction	yes

Trial Name	-
Novel drug target	Established target

blocker (inhibitory)
inhibitor (inhibitory)

blocker (inhibitory)
inhibitor (inhibitory)

TOLBUTAMIDE Drug Record

TOLBUTAMIDE chembl:CHEMBL782 Approved

Alternate Names:

Drug Info:

Publications:

TOLBUTAMIDE KCNJ1

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: 9647478 10455193 11226127

Sources: TdgClinicalTrial TEND

TOLBUTAMIDE ABCC8

Interaction Types & Directionality: blocker (inhibitory) inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker Direct Interaction yes

PMIDs: 18220763

Sources: ChemblInteractions TTD

TOLBUTAMIDE ABCC9

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: TTD

TOLBUTAMIDE KCNJ11

Interaction Types & Directionality: blocker (inhibitory) inhibitor (inhibitory)

Interaction Info: Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

TOLBUTAMIDE G6PD

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: PharmGKB FDA

TOLBUTAMIDE CYP2C9

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 8742240 32531309 27339126 25994031 15284535 11875364

Sources: PharmGKB

TOLBUTAMIDE CYP2C19

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 10411572 10022751

Sources: PharmGKB

TEND: TOLBUTAMIDE

Alternate Names: TOLBUTAMIDE Primary Drug Name

Drug Info: Drug Class hypoglycemic agents Year of Approval approved before 1982

Publications:

TdgClinicalTrial: TOLBUTAMIDE

Alternate Names:

Drug Info: Drug Indications Hypoglycemic Agents Drug Class small molecule FDA Approval Approved before 1982

Publications:

PharmGKB: tolbutamide

Alternate Names:

Drug Info:

TTD: Tolbutamide

Alternate Names: D06OIV TTD Drug ID

Drug Info:

Publications:

ChemblInteractions: CHEMBL782

Alternate Names:

Drug Info:

Publications:

ChemblDrugs: chembl:CHEMBL782

Alternate Names:

Drug Info:

Publications:

FDA: Tolbutamide

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
9647478 10455193 11226127

Sources:
TdgClinicalTrial TEND

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
18220763

Sources:
ChemblInteractions TTD

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TTD

Interaction Types & Directionality:

blocker (inhibitory)

inhibitor (inhibitory)

Interaction Info:

Mechanism of Interaction Sulfonylurea receptor 1, Kir6.2 blocker

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
PharmGKB FDA

Interaction Types & Directionality:

n/a

PMIDs:
8742240 32531309 27339126 25994031 15284535 11875364

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
10411572 10022751

Sources:
PharmGKB

Alternate Names:

TOLBUTAMIDE Primary Drug Name

Drug Info:

Drug Class hypoglycemic agents

Year of Approval approved before 1982

Drug Info:

Drug Indications Hypoglycemic Agents

Drug Class small molecule

FDA Approval Approved before 1982

Alternate Names:

D06OIV TTD Drug ID